Surgical treatment of central retinal vein occlusion

Acta Ophthalmologica

Volumn 86, Issue 3, 2008, Pages 245-252

  Berker, Nilufer ^a,b   Batman, Cosar ^a  

^a Ulucanlar Eye Research Hospital ^*  (Turkey)

^b Ulucanlar Eye Research Hospital   (Turkey)

Author keywords

Central retinal vein occlusion; Chorioretinal venous anastomosis; Radial optic neurotomy; Retinal vein cannulation; Surgical treatment; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; BEVACIZUMAB; STEROID; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN ANTIBODY;

BRAIN HEMORRHAGE; CATARACT; CENTRAL RETINA VEIN OCCLUSION; CHORIORETINAL VENOUS ANASTOMOSIS; CLINICAL TRIAL; DRUG MECHANISM; ENDOPHTHALMITIS; EPIRETINAL MEMBRANE; EYE SURGERY; EYE TOXICITY; HUMAN; INTERMETHOD COMPARISON; INTERNAL LIMITING MEMBRANE PEELNG; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LASER COAGULATION; LOW DRUG DOSE; LOW LEVEL LASER THERAPY; NEOVASCULAR GLAUCOMA; OCULAR TUBERCULOSIS; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIAL OPTIC NEUROTOMY; RETINA DETACHMENT; RETINA ISCHEMIA; RETINA MACULA EDEMA; RETINA TEAR; RETINA VEIN; REVIEW; SCOTOMA; SUBRETINAL NEOVASCULARIZATION; SURGICAL ANATOMY; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYSTEMIC THERAPY; TREATMENT INDICATION; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT; VITRECTOMY; VITREOUS BODY DETACHMENT; VITREOUS HEMORRHAGE;

ANASTOMOSIS, SURGICAL; CATHETERIZATION; CHOROID; EPIRETINAL MEMBRANE; FIBRINOLYTIC AGENTS; HUMANS; INJECTIONS, INTRAVENOUS; OPHTHALMOLOGIC SURGICAL PROCEDURES; OPTIC NERVE; RETINAL VEIN OCCLUSION; RETINAL VESSELS; TISSUE PLASMINOGEN ACTIVATOR; VITRECTOMY;

EID: 44649130106     PISSN: 1755375X     EISSN: 16000420     Source Type: Journal    
DOI: 10.1111/j.1755-3768.2007.01144.x     Document Type: Review

References (73)

1. Aiello LP, Avery RL, Arrigg PG et al. (1994): Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 331: 1480-1487.
2. Azad R & Verma D (2003): Does radial optic neurotomy induce surgical optociliary vessels in central retinal vein occlusion? Retina 23: 888-889.
3. Baumal CR & Brown GC (1997): Treatment of central retinal vein occlusion. Ophthalmic Surg Lasers 28: 590-600.
4. Binder S, Aggermann T & Brunner S (2007): Longterm effects of radial optic neurotomy for central retinal vein occlusion consecutive interventional case series. Graefes Arch Clin Exp Ophthalmol 245: 1447-1452.
5. Blumenkranz MS (2005): New therapy for central retinal vein occlusion. Are intravitreal steroids a possible answer? Arch Ophthalmol 123: 259-261.
6. Bynoe LA, Hutchins RK, Lazarus HS & Friedberg MA (2005): Retinal endovascular surgery for central retinal vein occlusion. Initial experience of four surgeons. Retina 25: 625-632.
7. Central Vein Occlusion Study Group (1993): Baseline and early natural history report. Arch Ophthalmol 111: 1087-1095.
8. Central Vein Occlusion Study Group (1997): Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 115: 486-491.
9. Chang MA, Fine HF, Bass E, Bressler SB, Schachat AP, Solomon SD & Bressler NM (2007): Patients'preferences in choosing therapy for retinal vein occlusions. Retina 27: 789-797.
10. Elman MJ (1996): Thrombolytic therapy for central retinal vein occlusion: Results of a pilot study. Trans Am Ophthalmol Soc 94: 471-504.
11. Eye Disease Case-Control Study Group (1996): Risk factors for central retinal vein occlusion. Arch Ophthalmol 114: 545-554.
12. Fekrat S & de Juan E Jr (1999): Chorioretinal venous anastomosis for central retinal vein occlusion: Transvitreal venipuncture. Ophthalmic Surg Lasers 30: 52-55.
13. Feltgen N, Junker B, Agostini H & Hansen LL (2007): Retinal endovascular lysis in ischaemic central retinal vein occlusion. One-year results of a pilot study. Ophthalmology 114: 716-723.
14. Friedman SM (2003): Optociliary venous anastomosis after radial optic neurotomy for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 34: 315-317.
15. Funatsu H, Yamashita H, Ikeda T, Mimura T, Eguchi S & Hori S (2003a): Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular oedema. Ophthalmology 110: 1690-1696.
16. Funatsu H, Yamashita H, Ikeda T, Mimura T, Shimizu E & Hori S (2003b): Relation of diabetic macular oedema to cytokines and posterior vitreous detachment. Am J Ophthalmol 135: 321-327.
17. Furino C, Ferrari TM, Boscia F, Cardascia N, Sborgia L, Reibald M, Ferreri P & Sborgia C (2005): Combined radial optic neurotomy, internal limiting membrane peeling, and intravitreal triamcinolone acetonide for central retinal vein occlusion. Ophthalmic Surg Lasers Imaging 36: 422-425.
18. Garcia-Arumi J, Boixadera A, Martinez- Castillo V, Castillo R, Dou A & Corcostegui B (2003): Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion. Arch Ophthalmol 121: 1385-1391.
19. Garcia-Arumi J, Boixadera A, Martinez-Castillo V, Montolio M, Verdugo A & Corcostegui B (2007): Radial optic neurotomy in central retinal vein occlusion: Comparison of outcome in younger versus older patients. Am J Ophthalmol 143: 134-140.
20. Gelston CD, Olson JL & Mandava N (2006): Macular oedema in central retinal vein occlusion treated with intravitreal triamcinolone. Acta Ophthalmol Scand 84: 314-318.
21. Glacet-Bernard A, Zourdani A & Milhoub M (2001): Effect of isovolaemic haemodilution in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 239: 909-914.
22. Green WR, Chan CC, Hutchins GM & Terry JM (1981): Central retinal vein occlusion: A prospective histopathologic study of 29 eyes in 28 cases. Trans Am Ophthalmol Soc 79: 371-422.
23. Greenberg PB, Martidis A, Rogers AH, Duker JS & Reichel E (2002): Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Br J Ophthalmol 86: 247-248.
24. Gumus K, Kadayifcilar S, Eldem B, Saracbasi O, Ozcebe O, Dundar S & Kirazli S (2006): Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion? Clin Experiment Ophthalmol 34: 305-311.
25. Hansen LL, Danisevskis P & Arntz HR (1985): A randomized prospective study on treatment of central retinal vein occlusion by isovolaemic haemodilution and photocoagulation. Br J Ophthalmol 69: 108-116.
26. Hansen LL, Wiek J & Wiederholt M (1989): A randomized prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution. Br J Ophthalmol 73: 895-899.
27. Hansen L, Kristensen HL, Bek T & Ingerslev J (2000): Markers of thrombophilia in retinal vein thrombosis. Acta Ophthalmol Scand 78: 523-526.
28. Hasselbach HC, Ruefer F, Feltgen N et al. (2007): Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases. Graefes Arch Clin Exp Ophthalmol 245: 1145-1156.
29. Hayreh SS (1983): Classification of central retinal vein occlusion. Ophthalmology 90: 458-474.
30. Hayreh SS (2003): Management of central retinal vein occlusion. Ophthalmologica 217: 167-188.
31. Höh AE, Schaal KB & Dithmar S (2007): Central and branch retinal vein occlusion. Current strategies for treatment in Germany, Austria and Switzerland. Ophthalmologe 104: 290-294.
32. Horio N & Horiguchi M (2006): Retinal blood flow and macular oedema after radial optic neurotomy for central retinal vein occlusion. Am J Ophthalmol 141: 31-34.
33. Hvarfner C & Larsson J (2006): Vitrectomy for non-ischaemic macular oedema in retinal vein occlusion. Acta Ophthalmol Scand 84: 812-814.
34. Hvarfner C, Hillarp A & Larsson J (2003): Influence of factor V Leiden on the development of neovascularization secondary to central retinal vein occlusion. Br J Ophthalmol 87: 305-306.
35. Ip MS & Kumar KS (2002): Intravitreous triamcinolone acetonide as treatment for macular oedema from central retinal vein occlusion. Arch Ophthalmol 120: 1217-1219.
36. Iturralde D, Spaide RF, Meyerle CB et al. (2006): Intravitreal bevacizumab (Avastin) treatment of macular oedema in central retinal vein occlusion: A short-term study. Retina 26: 279-284.
37. Kjeka O, Bredrup C & Krohn J (2007): Photopic 30-Hz flicker electroretinography predicts ocular neovascularization in central retinal vein occlusion. Acta Ophthalmol Scand 85: 640-643.
38. Koizumi K, Nishiura M, Yamamoto T, Machida T, Nakamura T, Ouchi M & Kinoshita S (2002): Intentional complete interruption of a retinal vein after vitrectomy might improve the rate of successful chorioretinal venous anastomosis formation in central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 240: 787-794.
39. Krepler K, Ergun E, Sacu S, Richter-Müksch S, Wagner J, Stur M & Wedrich A (2005): Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion. Acta Ophthalmol Scand 83: 71-75.
40. Lahey JM, Fong DS & Kearney J (1999): Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 30: 427-434.
41. Liang XL, Chen HY, Huang YS, Eong KGA, Yu SS, Liu X & Yan H (2007): Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: A pilot study. Ann Acad Med Singapore 36: 293-297.
42. Mandelcorn MS & Nrusimhadevara RK (2004): Internal limiting membrane peeling for decompression of macular oedema in retinal vein occlusion: A report of 14 cases. Retina 24: 348-355.
43. Martinez-Jardon CS, Meza-de Regil A, Dalma-Weiszhausz J, Leizaola-Fernandez C, Morales-Canton V, Guerrero-Naranjo JL & Quiroz-Mercado H (2005): Radial optic neurotomy for ischaemic central vein occlusion. Br J Ophthalmol 89: 558-561.
44. McAllister IL & Constable IJ (1995): Laser-induced chorioretinal venous anastomosis for treatment of non-ischaemic central retinal vein occlusion. Arch Ophthalmol 113: 456-462.
45. McAllister IL, Douglas JP, Constable IJ & Yu DY (1998): Laser-induced chorioretinal venous anastomosis for non-ischaemic central retinal vein occlusion: Evaluation of the complications and their risk factors. Am J Ophthalmol 126: 219-229.
46. Mirshahi A, Roohipoor R, Lashay A, Mohammadi SF & Mansouri MR (2005): Surgical induction of chorioretinal venous anastomosis in ischaemic central retinal vein occlusion: A non-randomized controlled clinical trial. Br J Ophthalmol 89: 64-69.
47. Mohamed Q, McIntosh RL, Saw SM & Wong TY (2007): Interventions for central retinal vein occlusion. An evidence-based systematic review. Ophthalmology 114: 507-519.
48. Nomoto H, Shiraga F, Yamaji H, Kageyama M, Takenaka H, Baba T & Tsuchida Y (2004): Evaluation of radial optic neurotomy for central retinal vein occlusion by indocyanine green videoangiography and image analysis. Am J Ophthalmol 138: 612-619.
49. Opremcak EM, Bruce RA, Lomeo MD, Ridenour CD, Letson AD & Rehmar AJ (2001): Radial optic neurotomy for central retinal vein occlusion. A retrospective pilot study of 11 consecutive cases. Retina 21: 408-415.
50. Opremcak EM, Rehmar AJ, Ridenour CD & Kurz DE (2006a): Radial optic neurotomy for central retinal vein occlusion: 117 consecutive cases. Retina 26: 297-305.
51. Opremcak EM, Rehmar AJ, Ridenour CD, Kurz DE & Borkowski LM (2006b): Radial optic neurotomy with adjunctive intraocular triamcinolone for central retinal vein occlusion: 63 consecutive cases. Retina 26: 306-313.
52. Parodi MB, Lanzetta P, Guarnaccia G & Friberg T (2003): Surgical treatments of central retinal vein occlusion. Semin Ophthalmol 18: 142-146.
53. Patelli F, Radice P, Zumbo G, Fasolino G & Marchi S (2004): Optical coherence tomography evaluation of macular oedema after radial optic neurotomy in patients affected by central retinal vein occlusion. Semin Ophthalmol 19: 21-24.
54. Peyman GA, Kishore K & Conway MD (1999): Surgical chorioretinal venous anastomosis for ischaemic central retinal vein occlusion. Ophthalmic Surg Lasers 30: 605-614.
55. Poulson AV, Snead DRJ, Jacobs PM, Ahmad N & Snead MP (2004): Intraocular surgery for optic nerve disorders. Eye 18: 1056-1065.
56. Quinlan PM, Elman MJ, Bhatt AK, Mardesich P & Enger C (1990): The natural course of central retinal vein occlusion. Am J Ophthalmol 110: 118-123.
57. Quiroz-Mercado H, Sanchez-Buenfil E, Guerrero-Naranjo JL, Ochoa-Contreras D, Ruiz-Cruz M, Marcellino G & Damico DJ (2001): Successful erbium:YAG laser-induced chorioretinal venous anastomosis for the management of ischaemic central retinal vein occlusion. A report of two cases. Graefes Arch Clin Exp Ophthalmol 239: 872-875.
58. Radetzky S, Walter P, Fauser S, Koizumi K, Kirchhof B & Joussen AM (2004): Visual outcome of patients with macular oedema after pars plana vitrectomy and indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 242: 273-278.
59. Rath EZ, Frank RN, Shin DH & Kim C (1992): Risk factors for retinal vein occlusions. A case-control study. Ophthalmology 99: 509-514.
60. Saika S, Tanaka T, Miyamoto T & Ohnishi Y (2001): Surgical posterior vitreous detachment combined with gas/air tamponade for treating macular oedema associated with branch retinal vein occlusion: Retinal tomography and visual outcome. Graefes Arch Clin Exp Ophthalmol 239: 729-732.
61. Shahid H, Hossain P & Amoaku WM (2006): The management of retinal vein occlusion: Is interventional ophthalmology the way forward? Br J Ophthalmol 90: 627-639.
62. Sharma A & D'Amico D (2004): Medical and surgical management of central retinal vein occlusion. Int Ophthalmol Clin 44: 1-16.
63. Spaide RF, Klancnik JM Jr & Gross NE (2004): Retinal choroidal collateral circulation after radial optic neurotomy correlated with the lessening of macular oedema. Retina 24: 356-359.
64. Stahl A, Agostini H, Hansen LL & Feltgen N (2007): Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol 245: 1429-1436.
65. Stefansson E, Novack RL & Hatchell DL (1990): Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31: 284-289.
66. Tachi N, Hashimoto Y & Ogino N (1999): Vitrectomy for macular oedema combined with retinal vein occlusion. Doc Ophthalmol 97: 465-469.
67. Tsujikawa A, Hangai M, Kikuchi M, Ishida K & Kurimoto Y (2006): Visual field defect after radial optic neurotomy for central retinal vein occlusion. Jpn J Ophthalmol 50: 158-160.
68. Vinores SA, Youssri AI, Luna JD et al. (1997): Upregulation of vascular endothelial growth factor in ischaemic and non-ischaemic human and experimental retinal disease. Histol Histopathol 12: 99-109.
69. Weiss JN & Bynoe LA (2001): Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 108: 2249-2257.
70. Weizer JS, Stinnett SS & Fekrat S (2003): Radial optic neurotomy for central retinal vein occlusion. Am J Ophthalmol 136: 814-819.
71. Williamson TH (1997): CentWal retinal vein occlusion: what's the story? Br J Ophthalmol 81: 698-704.
72. Williamson TH, Poon W, Whitefield L, Strothidis N & Jaycock P (2003): A pilot study of pars plana vitrectomy, intraocular gas and radial neurotomy in ischaemic central retinal vein occlusion. Br J Ophthalmol 87: 1126-1129.
73. Zambarakji HJ, Ghazi-Nouri S, Schadt M, Bunce C, Hykin PG & Charteris DG (2005): Vitrectomy and radial optic neurotomy for central retinal vein occlusion: Effects on visual acuity and macular anatomy. Graefes Arch Clin Exp Ophthalmol 243: 397-405.